Join Now
Why Join?
Log In
Your Username/Email:
Your Password:
Remember Me
Forgot your password?
or
Home
Stocks
ETFs
Futures
Forex
Funds
Economy
Education
My Barchart
Market Pulse
Indices
Signals
Hot Stocks
Sectors
Portfolio Blogs
News & Commentary
Stock Screener
Enter ticker symbol
Extended Search
Symbol Search
Select a Commodity
--Grains and Oilseeds--
Wheat
Corn
Soybeans
Soybean Meal
Soybean Oil
Oats
Rough Rice
KCBT Wheat
Spring Wheat
Canola
--Currencies--
U.S. Dollar Index
British Pound
Canadian Dollar
Japanese Yen
Swiss Franc
Euro FX
Australian Dollar
Mexican Peso
--Energies--
Crude Oil
Heating Oil
Gasoline RBOB
Natural Gas
Ethanol
--Financials--
30 Year T-Bond
10 Year T-Note
5 Year T-Note
2 Year T-Note
10-Year Swaps
5-Year Swaps
30 Day Fed Funds
Eurodollar
--Indices--
S&P 500 Index
E-Mini S&P 500
Nasdaq 100
E-Mini Nasdaq
Dow Industrials
E-Mini Dow
NYSE Composite
S&P Midcap 400
E-Mini S&P Midcap
E-Mini Russell 2000
E-Mini SmallCap 600
CRB CCI Index
--Meats--
Live Cattle
Feeder Cattle
Lean Hogs
Pork Bellies
CME Milk
--Metals--
Gold
Silver
High Grade Copper
Platinum
Palladium
NYSE Gold
NYSE Silver
--Softs--
Cotton #2
Orange Juice
Coffee
Sugar #11
Cocoa
Sugar #16
Lumber
or enter GC* - Gold Futures
Quotes and Charts
Quote
Detailed Quote
Options Quotes
Technical Chart
Interactive Chart
Technical Analysis
Technical Analysis
Trader's Cheat Sheet™
Barchart Opinions
Barchart Opinion
Snapshot Opinion
Trading Strategies
Company Info
News Headlines
Profile
Key Statistics
Earnings
Analyst Ratings
Ratios
Income Statement
Balance Sheet
YOU ARE HERE:
Stocks
» Quotes and Charts » Quote
Symbols:
Top Stocks
Futures Markets
My Stocks
Save
Cancel
+ Portfolio
Biogen Idec Inc (BIIB)
131.56
-0.09 (-0.07%)
7:35P EST
(NASDAQ)
-
Stock Price Quote as of
Friday, May 25th, 2012
High
132.90
Low
131.07
52Wk High
138.49
Since 05/16/12
(-5.00%)
52Wk Low
83.83
Since 08/09/11
(+56.94%)
Open
132.25
Prev Close
131.65
Volume
757,100
Avg Volume
1,347,280
EPS
+5.08
Div & Yield
N/A
P/E Ratio
22.66
Market Cap
$31.41 B
Weighted Alpha
+42.10
Standard Dev
-0.05
Sectors
Medical - Biomedical
,
All BIIB Sectors
View Detailed Quote
Chart Snapshot
Customize Chart
Barchart Opinion
View Opinion
Strong Buy
Buy
Hold
Sell
Strong Sell
Support & Resistance
Get Cheat Sheet
2nd Resistance Point
133.67
1st Resistance Point
132.62
Last Price
131.56
1st Support Level
130.79
2nd Support Level
130.01
Latest Headlines
More Headlines
Biogen Tysabri Canadian Label Update - Analyst Blog
Zacks Investment Research - Fri May 25, 4:44PM CDT
AVEO's AV-203 in Phase I - Analyst Blog
Zacks Investment Research - Thu May 24, 5:33PM CDT
36.7% Return Seen to Date on SmarTrend Biogen Idec Call (BIIB)
Comtex SmarTrend(R) - Wed May 23, 9:07AM CDT
Health Canada Approves Updates to TYSABRI® (natalizumab) Product Monograph to Include Anti-JC Virus Antibody Status
CNW Group - Wed May 23, 8:17AM CDT
EnVivo Pharmaceuticals names Dr Alfred Sandrock to board
M2 - Wed May 23, 6:10AM CDT
EnVivo Pharmaceuticals Appoints Alfred Sandrock, M.D., Ph.D., to Board of Directors
BusinessWire - Tue May 22, 7:30AM CDT
The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan
PR Newswire - Mon May 21, 8:30AM CDT
Biogen Idec Earnings Hindsight: Down 0.3% in Last 20 Days (BIIB)
Comtex SmarTrend(R) - Mon May 21, 7:23AM CDT
Critical Alerts For Qualcomm, Simon Property, Silver Wheaton, Biogen Idec, and Nu Skin Released By InvestorsObserver
PR Newswire - Fri May 18, 8:31AM CDT
New Analysis of Risk Stratification for TYSABRI(R) Published in New England Journal of Medicine
BusinessWire - Thu May 17, 2:40PM CDT